Bullets and Ballots

Researching the rare, but all-too-common, disease of gun violence in America will take a concerted political effort.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ANDRZEJ KRAUZEThis issue of The Scientist is devoted to the science, funding, and drug development directed toward rare diseases. As illustrated here, various countries define “rare” in this context differently: in Chile, for example, a disease is rare if it afflicts at most 50 out of 100,000 citizens, while in South Korea, no more than 5 people out of 100,000 may suffer from the malady for it to be categorized as rare.

But in the U.S.—where diseases are deemed rare if they affect 64 out of 100,000 people or fewer—recent tragedies demand that we take a look at another scourge that claims lives at an alarming rate: the disease of gun violence. According to researchers at the US Centers for Disease Control and Prevention (CDC), more than 32,000 Americans die and more than 67,000 people are injured by firearms each year (Prev Med, 79:5-14, 2015). Those same researchers more recently estimated that 1,300 US children die from gunshot wounds every year, and almost 5,800 are injured by firearms. Using just a year’s worth of these statistics, almost 10 Americans out of every 100,000 suffer the ill effects of gun violence—meaning one could think of gun violence as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Published In

May 2018

Rare Diseases

The realities of studying uncommon conditions

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies